P3 Health Partners Inc. (NASDAQ:PIII) Short Interest Update

Key Points

• P3 Health Partners Inc. experienced a significant 29.5% drop in short interest in August, with short interest totaling 24,900 shares as of August 15th.
• The company reported a quarterly loss of ($6.23) EPS, missing the consensus estimate of ($3.29), and had revenue of $355.79 million.
• Lake Street Capital has initiated coverage on P3 Health Partners with a "buy" rating and a price target of $20.00, reflecting positive sentiment from analysts.

P3 Health Partners Inc. (NASDAQ:PIII - Get Free Report) was the target of a significant decline in short interest during the month of August. As of August 15th, there was short interest totaling 24,900 shares, a decline of 29.5% from the July 31st total of 35,300 shares. Approximately 1.4% of the company's shares are short sold. Based on an average daily trading volume, of 7,700 shares, the short-interest ratio is currently 3.2 days. Based on an average daily trading volume, of 7,700 shares, the short-interest ratio is currently 3.2 days. Approximately 1.4% of the company's shares are short sold.

P3 Health Partners Trading Down 0.6%

P3 Health Partners stock traded down $0.06 during trading on Thursday, reaching $8.62. The company had a trading volume of 5,269 shares, compared to its average volume of 7,117. P3 Health Partners has a 12-month low of $5.80 and a 12-month high of $29.00. The company has a debt-to-equity ratio of 2.29, a quick ratio of 0.31 and a current ratio of 0.31. The stock's 50 day moving average price is $7.26 and its two-hundred day moving average price is $7.82. The firm has a market capitalization of $62.01 million, a price-to-earnings ratio of -0.19 and a beta of 0.82.

P3 Health Partners (NASDAQ:PIII - Get Free Report) last announced its quarterly earnings results on Thursday, August 14th. The company reported ($6.23) earnings per share for the quarter, missing analysts' consensus estimates of ($3.29) by ($2.94). P3 Health Partners had a negative net margin of 9.99% and a negative return on equity of 183.60%. The company had revenue of $355.79 million during the quarter, compared to analyst estimates of $356.52 million. P3 Health Partners has set its FY 2025 guidance at EPS. As a group, equities analysts expect that P3 Health Partners will post -0.67 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Lake Street Capital initiated coverage on shares of P3 Health Partners in a research note on Thursday, August 28th. They issued a "buy" rating and a $20.00 target price for the company. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat, P3 Health Partners has a consensus rating of "Moderate Buy" and a consensus target price of $16.25.

Institutional Investors Weigh In On P3 Health Partners

A number of institutional investors have recently added to or reduced their stakes in PIII. Wealthedge Investment Advisors LLC acquired a new stake in P3 Health Partners during the fourth quarter worth about $83,000. Abundance Wealth Counselors grew its holdings in shares of P3 Health Partners by 77.3% during the 1st quarter. Abundance Wealth Counselors now owns 400,000 shares of the company's stock worth $66,000 after purchasing an additional 174,395 shares during the period. Cresset Asset Management LLC lifted its position in P3 Health Partners by 33.3% during the first quarter. Cresset Asset Management LLC now owns 200,000 shares of the company's stock valued at $33,000 after buying an additional 50,000 shares in the last quarter. Finally, Trinity Financial Advisors LLC grew its stake in P3 Health Partners by 22.5% during the first quarter. Trinity Financial Advisors LLC now owns 1,278,037 shares of the company's stock worth $222,000 after buying an additional 234,500 shares during the period. Hedge funds and other institutional investors own 7.75% of the company's stock.

P3 Health Partners Company Profile

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.